Explore the full management transaction log of Diversicare Healthcare Services, Inc., a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Diversicare Healthcare Services, Inc. has recorded 24 public disclosures. The latest transaction was disclosed on 22 November 2021 (Disposition). Among the most active insiders: Osmium Partners, LLC. Every trade is accessible without an account.
24 of 24 declarations
Diversicare Healthcare Services, Inc. (ticker: DVCR) is a U.S.-based post-acute care operator listed on the NASDAQ in the United States. The company focuses on skilled nursing centers, complemented by rehabilitative services, ancillary healthcare services, and, at some locations, assisted living. Its business model is centered on patients and residents who need extended recovery and long-term support after hospitalization, which makes the company highly sensitive to reimbursement trends and healthcare policy changes. ([sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) Diversicare was incorporated as a Delaware corporation in 1994 and built its footprint through a regional network of facilities across multiple U.S. states. SEC filings describe a historical presence mainly in the Southeast, Midwest, and Southwest, with corporate headquarters in Brentwood, Tennessee. That regional concentration gives the company access to localized demand pools, especially in markets where aging demographics and post-acute care needs support long-term utilization. ([sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) Operationally, Diversicare’s core business lines include skilled nursing beds, physical/occupational/speech therapy services, respiratory services, nutritional support, and other specialized ancillary care. In industry terms, the company is positioned as a post-acute care provider rather than a broad acute-care hospital chain. Its competitive strengths are typically found in care integration, clinical expertise with medically complex patients, and facility-level proximity to community demand. ([sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) The competitive landscape is intense and heavily regulated. Skilled nursing providers operate under federal and state oversight, and profitability depends in large part on the payor mix, especially Medicare and Medicaid reimbursement economics. SEC risk disclosures highlight pressure on reimbursement rates, exposure to higher-acuity patient volumes, and the costs of compliance. For investors, that means the business can benefit from stable local demand, but it remains structurally margin-sensitive. ([sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) A notable recent development was a merger agreement announced in 2021, underscoring outside strategic interest in the franchise, although the final outcome and current structure should be checked against the latest SEC filings. For investors and market participants, DVCR should be viewed as a small-cap healthcare services name on NASDAQ in the United States, with performance driven by occupancy, reimbursement, labor costs, and regulatory execution rather than by product innovation or national scale. ([sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000067/areannouncementofmergeragr.htm?utm_source=openai))